These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3106066)

  • 1. In vitro studies on human IgD. II. IgD-secreting cells preferentially elaborate IgD, lambda molecules.
    Litwin SD; Zehr BD
    Eur J Immunol; 1987 Apr; 17(4):491-5. PubMed ID: 3106066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on human IgD. I. Sources and characteristics of "externalized" IgD in tonsil lymphocyte cultures.
    Litwin SD; Zehr BD
    Eur J Immunol; 1987 Apr; 17(4):483-9. PubMed ID: 3494617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light chain types of IgD in human bone marrow and serum.
    van Nieuwkoop JA; Radl J
    Clin Exp Immunol; 1985 Jun; 60(3):654-60. PubMed ID: 3926359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo generation of murine IgD-secreting cells is accompanied by deletion of the C mu gene and occasional deletion of the gene for the C delta 1 domain.
    Mountz JD; Mushinski JF; Owens JD; Finkelman FD
    J Immunol; 1990 Sep; 145(5):1583-91. PubMed ID: 1696602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane IgD-positive B cells of "low-IgD serum phenotype" individuals fail to secrete IgD and fail to shift to preferential lambda light-chain expression in vitro.
    Litwin SD; Zehr BD
    J Clin Immunol; 1987 Mar; 7(2):114-20. PubMed ID: 3106400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of IgM and IgD expression in human B-lineage cells.
    Kerr WG; Hendershot LM; Burrows PD
    J Immunol; 1991 May; 146(10):3314-21. PubMed ID: 1902853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B cells secrete predominantly lambda L chains in the absence of H chain expression.
    Ambrosino DM; Kanchana MV; Delaney NR; Finberg RW
    J Immunol; 1991 Jan; 146(2):599-602. PubMed ID: 1898958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa/lambda ratio in surface immunoglobulin molecules on B lymphocytes differentiating from DHJH-rearranged murine pre-B cell clones in vitro.
    Rolink A; Streb M; Melchers F
    Eur J Immunol; 1991 Nov; 21(11):2895-8. PubMed ID: 1936127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion.
    Mountz JD; Smith J; Snapper CM; Mushinski JF; Finkelman FD
    J Immunol; 1987 Oct; 139(7):2172-8. PubMed ID: 3498752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies on human IgD. III. Immunologic features of individuals with high sera IgD and spontaneous IgD biosynthesis.
    Litwin SD; Zehr BD
    Clin Immunol Immunopathol; 1988 Apr; 47(1):75-83. PubMed ID: 3127095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature B cells from human and mouse bone marrow can change their surface light chain expression.
    Ghia P; Gratwohl A; Signer E; Winkler TH; Melchers F; Rolink AG
    Eur J Immunol; 1995 Nov; 25(11):3108-14. PubMed ID: 7489750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of immunoglobulin heavy chain expression results in altered kappa/lambda light chain ratios.
    Holmberg D; Lundkvist I; Forni L; Ivars F; Coutinho A
    J Mol Cell Immunol; 1985; 2(1):51-6. PubMed ID: 3939751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Moore TL
    Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IgD on B cell malignancy. An immunopathological study of 50 cases.
    Mori S; Hagiwara S; Kodo H; Mohri N
    Acta Pathol Jpn; 1986 Oct; 36(10):1429-40. PubMed ID: 3099539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for the development of human IgD-only B cells: Genotypic analyses suggest their generation in superantigen driven immune responses.
    Seifert M; Steimle-Grauer SA; Goossens T; Hansmann ML; Bräuninger A; Küppers R
    Mol Immunol; 2009 Feb; 46(4):630-9. PubMed ID: 18952293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Ig on human lymphocytes: rate of turnover of IgD and IgM on the surface of human tonsil cells.
    Ferrarini M; Corte G; Viale G; Durante ML; Bargellesi A
    Eur J Immunol; 1976 May; 6(5):372-8. PubMed ID: 991908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells.
    Ferrarini M; Viale G; Risso A; Pernis B
    Eur J Immunol; 1976 Aug; 6(8):562-5. PubMed ID: 824142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression.
    Bogen B; Weiss S
    Eur J Immunol; 1991 Oct; 21(10):2391-5. PubMed ID: 1915552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.